Working… Menu

Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03000660
Recruitment Status : Terminated (partial clinical hold per FDA)
First Posted : December 22, 2016
Last Update Posted : August 21, 2020
Information provided by (Responsible Party):
Tufts Medical Center

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : October 2019
Actual Study Completion Date : October 10, 2019